Loading
An early trial studying the safety and activity of experimental treatment. Its registry status does not establish patient benefit.
A Study of FDA018-ADC in Patients With Advanced Solid Tumors. ClinicalTrials.gov record last updated 2026-01-23: active not recruiting. Enrollment is planned at 78 participants. Primary completion is estimated at 2029-12. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.
Shares FDA018-ADC, TROP2.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/